User Tools

Site Tools


Action disabled: revisions
nps

novel psychoactive substances (NPS)

Introduction

  • many of these drugs are transient on the marketplace
  • in 2021, the Victorian Coroner had identified 5 recent cases of deaths from 25C-NBOme and 5-flouroamphetamine with the victims thinking they were taking ecstasy or psilocybin.

25C-NBOme

  • a designer NPS in the class N methoxybenzyl substituted 2C phenylethylamine hallucinogens
  • street names include: “C-Boom”, “Cimbi-82”, “Pandora”, “Dime”
  • available as powder, pills or as blotting paper
  • highly potent
  • can be taken by placement under tongue or in cheek, swallowed or by nasal ingestion
  • can cause severe hallucinogenic effects, such as extreme patterning, vibrant coloring, euphoria, acceleration of thought and time distortion
  • potential complications:
    • hyperthermia
    • seizures
    • metabolic acidosis
    • rhabdomyolysis and hyperkaelamia
    • organ failure
    • death

5-flouroamphetamine (4-FA or 4-FMP)

  • known as “Flux”, “FIFA”
  • psycomotor stimulant 1st synthesized in the 1940s
  • has been found in products sold as ecstasy and amphetamine powders, and as an adulterant
  • may be able to act as a monoamine oxidase inhibitors (MAOIs)
  • acts similar to cocaine and amphetamines, and increases extracellular levels of dopamine, norepinephrine and serotonin.
  • severe toxity may cause:
    • severe cardiovascular complications
    • intracerebral haemorrhage
nps.txt · Last modified: 2021/07/29 17:44 by gary1